Renard E - Search Results

1

CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance.

Chavey C, Lazennec G, Lagarrigue S, Clapé C, Iankova I, Teyssier J, Annicotte JS, Schmidt J, Mataki C, Yamamoto H, Sanches R, Guma A, Stich V, Vitkova M, Jardin-Watelet B, Renard E, Strieter R, Tuthill A, Hotamisligil GS, Vidal-Puig A, Zorzano A, Langin D, Fajas L. Chavey C, et al. Among authors: renard e. Cell Metab. 2009 Apr;9(4):339-49. doi: 10.1016/j.cmet.2009.03.002. Cell Metab. 2009. PMID: 19356715 Free PMC article.

2

[Interrelation of visceral fat and muscle mass in non insulin-dependent diabetes (type II): practical implications].

Brun JF, Bringer J, Raynaud E, Renard E, Orsetti A. Brun JF, et al. Among authors: renard e. Diabetes Metab. 1997 Nov;23 Suppl 4:16-34. Diabetes Metab. 1997. PMID: 9463021 Review. French.

3

[Insulin sensitivity and polycystic ovarian syndrome].

Bringer J, Raingeard I, Renard E, Grigorescu F, Lefebvre P. Bringer J, et al. Among authors: renard e. Diabetes Metab. 2001 Apr;27(2 Pt 2):239-45. Diabetes Metab. 2001. PMID: 11452217 Review. French.

4

Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France.

Attaoua R, Ait El Mkadem S, Lautier C, Kaouache S, Renard E, Brun JF, Fedou C, Gris JC, Bringer J, Grigorescu F. Attaoua R, et al. Among authors: renard e. Diabetes Metab. 2009 Dec;35(6):476-83. doi: 10.1016/j.diabet.2009.07.002. Diabetes Metab. 2009. PMID: 19818665

5

Reduction of fat accumulation and lipid disorders by individualized light aerobic training in human immunodeficiency virus infected patients with lipodystrophy and/or dyslipidemia.

Thöni GJ, Fedou C, Brun JF, Fabre J, Renard E, Reynes J, Varray A, Mercier J. Thöni GJ, et al. Among authors: renard e. Diabetes Metab. 2002 Nov;28(5):397-404. Diabetes Metab. 2002. PMID: 12461477

6

Subcutaneous insulin resistance successfully circumvented on long term by peritoneal insulin delivery from an implantable pump in four diabetic patients.

Riveline JP, Vantyghem MC, Fermon C, Brunet C, Gautier JF, Renard E, Charpentier G; EVADIAC group. Riveline JP, et al. Among authors: renard e. Diabetes Metab. 2005 Nov;31(5):496-8. doi: 10.1016/s1262-3636(07)70221-5. Diabetes Metab. 2005. PMID: 16357794

7

Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients: results of a multicentric, comparative study.

Dufaitre-Patouraux L, Riveline JP, Renard E, Melki V, Belicar-Schaepelynck P, Selam JL, Guerci B, Millot L, Brun JM, Fermon C, Catargi B, Gin H, Jeandidier N, Lejeune PJ, Lassmann-Vague V. Dufaitre-Patouraux L, et al. Among authors: renard e. Diabetes Metab. 2006 Nov;32(5 Pt 1):427-32. doi: 10.1016/s1262-3636(07)70300-2. Diabetes Metab. 2006. PMID: 17110897 Clinical Trial.

8

Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes.

Renard E. Renard E. Diabetes Metab. 2009 Dec;35(6 Pt 2):564-8. doi: 10.1016/S1262-3636(09)73467-6. Diabetes Metab. 2009. PMID: 20152745 Review.

9

Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system.

Renard E, Costalat G, Chevassus H, Bringer J. Renard E, et al. Diabetes Metab. 2006 Dec;32(5 Pt 2):497-502. doi: 10.1016/s1262-3636(06)72802-6. Diabetes Metab. 2006. PMID: 17130808 Review.

10

Implantable insulin pumps. A position statement about their clinical use.

Renard E, Schaepelynck-Bélicar P; EVADIAC Group. Renard E, et al. Diabetes Metab. 2007 Apr;33(2):158-66. doi: 10.1016/j.diabet.2006.10.004. Epub 2007 Feb 14. Diabetes Metab. 2007. PMID: 17300973

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

464 results

Search Page